variant,gene_symbol,summary,clinical_importance,evidence,impact,frequency,category,inheritance,zygosity,PMIDs,dbSNP_ID,penetrance_score,build_37_chromosome,build_37_position,build_37_variant_allele,getev_report_url
PMM2-R141H,PMM2,"Several different genetic testing groups report this variant causes Carbohydrate-deficient glycoprotein syndrome type I, as recorded in ClinVar (http://www.ncbi.nlm.nih.gov/clinvar/RCV000008145/). ExAC allele frequency data appears to contradict this, as the allele frequency is relatively high: according to their data, 1 in 8,000 with European descent are expected to be homozygous. This seems to be more common than the disease itself, and would seem to contradict this reported effect. However, ExAC data also indicates this may be a low-quality site for sequencing (which may affect ExAC data, and other exome or whole genome data).",High,Uncertain,Pathogenic,0.004,Other,Recessive,Heterozygous,,,5,chr16,8905010,A,http://evidence.pgp-hms.org/genomes?display_genome_id=964cc8fd3eb6ce92f25f4f0169ef0826cd995167&access_token=2a3c402922d936bbb85e6783682b7057
LPL-N318S,LPL,"Also called N291S, this variant has been associated with high hypertriglyceridemia. According to data from Wright et al., carriers of this variant may be two to three times more likely to have very high triglyceride levels, although it is unknown what effect this may have on coronary heart disease.",Moderate,Uncertain,Pathogenic,0.013,Heart and circulatory;Metabolism,Dominant,Heterozygous,18068174,rs268,3,chr8,19813529,G,http://evidence.pgp-hms.org/genomes?display_genome_id=964cc8fd3eb6ce92f25f4f0169ef0826cd995167&access_token=2a3c402922d936bbb85e6783682b7057
COL4A1-Q1334H,COL4A1,"This common variant has been associated with arterial stiffness and, in Japanese, a small increased risk of myocardial infarction (MI, a.k.a. heart attack). This last observation supported a dominant effect for this variant and, assuming a lifetime risk of 15% for MI, we estimate carriers have an additional risk of 0.5-3%.",Low,Likely,Pathogenic,0.32,Heart and circulatory,Dominant,Heterozygous,10334796;18077766;20031579,rs3742207,2,chr13,110818598,G,http://evidence.pgp-hms.org/genomes?display_genome_id=964cc8fd3eb6ce92f25f4f0169ef0826cd995167&access_token=2a3c402922d936bbb85e6783682b7057
rs5186,,"This common noncoding genetic variant has an allele frequency of ~30% and is associated with an increased risk of hypertension. If ~25% of non-carriers have hypertension, Bonnardeaux et al's data predict ~4% increased risk of hypertension per copy of this variant. This SNP is in the 3' noncoding region of the AGTR1 transcript (angiotensin II type 1 receptor), also known as AT2R1 or AT1R, which is a target of hypertension drugs.",Low,Likely,Pathogenic,0.21,Drug response;Heart and circulatory,Unknown,Heterozygous,"8021009;
11250978;11593098;16046653;16675453;17668390",rs5186,2,chr3,148459988,C,http://evidence.pgp-hms.org/genomes?display_genome_id=964cc8fd3eb6ce92f25f4f0169ef0826cd995167&access_token=2a3c402922d936bbb85e6783682b7057
MTRR-I49M,MTRR,"This common variant (HapMap allele frequency of 31.3%) in a protein involved in folate (B9) and cobalamin (B12) metabolism and is often reported as ""MTRR I22M"" (an alternative transcript position). Mothers homozygous for this variant are associated with having around a increased chance of a child with Down syndrome (risk of 0.4%, average risk in population is 0.25%). Notably, age plays a far larger role in the rate of Down syndrome (risk is 4.5% for a mother 45-years-of-age), and it is unknown how this variant may combine with the effect of age. There are conflicting reports associating this variant with incidence of neural tube defects, possibly when combined with MTHFR A222V.",Low,Likely,Pathogenic,0.45,Anatomical and congenital;Metabolism;Nervous system,Recessive,Heterozygous,10444342;10930360;11807890;12375236;15060097;15979034;17024475,rs1801394,1,chr5,7870973,G,http://evidence.pgp-hms.org/genomes?display_genome_id=964cc8fd3eb6ce92f25f4f0169ef0826cd995167&access_token=2a3c402922d936bbb85e6783682b7057
CETP-A390P,CETP,"This variant is associated with slightly lower HDL (good) cholesterol, although it has a negligible effect (around 2 mg/dl).",Low,Likely,Pathogenic,0.039,Metabolism,Unknown,Heterozygous,17952847,rs5880,1,chr16,57015091,C,http://evidence.pgp-hms.org/genomes?display_genome_id=964cc8fd3eb6ce92f25f4f0169ef0826cd995167&access_token=2a3c402922d936bbb85e6783682b7057
WFS1-R611H,WFS1,"This nonsynonymous SNP is associated with Wolfram Syndrome (known as DIDMOAD), which is characterized by early-onset non-autoimmune diabetes mellitus, diabetes insipidus, optic atrophy, and deafness) and to adult Type Two Diabetes Mellitus.  The WFS1 gene maps to chromosome 4p16.3.  The variant has been shown to be statistically associated with type II diabetes in six UK studies and one study of Ashkenazi Jews (Sandhu, M., et al., Minton et al.).",Low,Uncertain,Not Reviewed,0.4,Hearing and vision;Immune system;Metabolism,Recessive,Homozygous,17603484;17719176;23257691,rs734312,1,chr4,6303354,A,http://evidence.pgp-hms.org/genomes?display_genome_id=964cc8fd3eb6ce92f25f4f0169ef0826cd995167&access_token=2a3c402922d936bbb85e6783682b7057
H6PD-R453Q,H6PD,"This common variant may have a small pathogenic effect by contributing to cortisone reductase deficiency (a rare abnormality) when homozygous and combined with a serious pathogenic variant. The same authors have tested and ruled out a contribution to polycystic ovary syndrome (similar phenotype, more common disease).",Low,Uncertain,Pathogenic,0.31,Genital and urinary;Metabolism,Recessive,Homozygous,12858176;15827106;16817821,rs6688832,1,chr1,9323910,A,http://evidence.pgp-hms.org/genomes?display_genome_id=964cc8fd3eb6ce92f25f4f0169ef0826cd995167&access_token=2a3c402922d936bbb85e6783682b7057
ELAC2-S217L,ELAC2,"Reported to be associated with increased susceptibility to prostate cancer, but later studies weaken the hypothesis. Xu et al.'s meta-analysis concludes that there is a small but significant increased risk (OR = 1.13). Assuming a lifetime risk of 16% for prostate cancer we calculate this leads to an increased risk of ~1.5% (17.5% total).",Low,Uncertain,Pathogenic,0.27,Cancer;Genital and urinary,Complex/Other,Heterozygous,12384782;15368467;18767027;20231859,rs4792311,2,chr17,12915009,A,http://evidence.pgp-hms.org/genomes?display_genome_id=964cc8fd3eb6ce92f25f4f0169ef0826cd995167&access_token=2a3c402922d936bbb85e6783682b7057
TGIF1-P83Shift,TGIF1,"Severe variants in this gene are associated with holoprosencephaly disorders when combined with loss-of-function variants in SHH. Haploinsufficiency was identified in some families with this condition. It is unclear how likely this variant is to occur in combination with an SHH variant, or what phenotypic effect the variant would have on its own.",Low,Uncertain,Pathogenic,0.14,Nervous system,Complex/Other,Heterozygous,10556296,rs11571510,1,,,,http://evidence.pgp-hms.org/genomes?display_genome_id=964cc8fd3eb6ce92f25f4f0169ef0826cd995167&access_token=2a3c402922d936bbb85e6783682b7057
TGFB1-R25P,TGFB1,"This variant in a growth factor gene is associated with variation in TGFB1 levels; this has been associated with various pathogenic and some protective effects, including: more hepatic fibrosis progression in hep C patients, lower risk of cleft palate, anticorrelation with longevity, higher risk of myocardial infarction and lower risk of hypertension.",Low,Uncertain,Pathogenic,0.049,Anatomical and congenital;Heart and circulatory,Complex/Other,Heterozygous,8901839;14596813;15212689;15569360,rs1800471,2,chr19,41858876,G,http://evidence.pgp-hms.org/genomes?display_genome_id=964cc8fd3eb6ce92f25f4f0169ef0826cd995167&access_token=2a3c402922d936bbb85e6783682b7057
BRCA2-N372H,BRCA2,"This is a common variant of BRCA2 (HapMap allele frequency of 23%). The variant is weakly associated with an increased chance of breast cancer, and zygosity of the variant is associated with sex of children: male children are more likely to be homozygous for this variant, female children are more likely to be heterozygous.",Low,Uncertain,Pathogenic,0.24,Cancer,Recessive,Heterozygous,11062481;15235023,rs144848,2,chr13,32906729,C,http://evidence.pgp-hms.org/genomes?display_genome_id=964cc8fd3eb6ce92f25f4f0169ef0826cd995167&access_token=2a3c402922d936bbb85e6783682b7057
ELAC2-A541T,ELAC2,"This variant is implicated as causing increased susceptibility to prostate cancer. However the variant has always been seen paired with S217L, it is unclear which variant is causal. Evidence is weak for both; one meta-analysis (Severi et al.) concluded that neither variant was pathogenic, a more recent meta-analysis (Xu et al.) found the data to be significant but the odds ratio was not strong and concluded they are ""low-penetrance susceptibility markers of prostate cancer"".",Low,Uncertain,Pathogenic,0.028,Cancer;Genital and urinary,Unknown,Heterozygous,10986046;11175785;11431329;12373607;12515253;12783937;18767027;20231859,rs34152967,2,chr17,12899902,T,http://evidence.pgp-hms.org/genomes?display_genome_id=964cc8fd3eb6ce92f25f4f0169ef0826cd995167&access_token=2a3c402922d936bbb85e6783682b7057
CLEC7A-Y238X,CLEC7A,This variant has been found to impair homan mucosal antifungal defense and was implicated in vulvovaginal candidiasis and mucocutaneous infections in a Dutch family.,Low,Uncertain,Pathogenic,0.063,Genital and urinary;Skin,Recessive,Heterozygous,19864674,rs16910526,4,chr12,10271087,C,http://evidence.pgp-hms.org/genomes?display_genome_id=964cc8fd3eb6ce92f25f4f0169ef0826cd995167&access_token=2a3c402922d936bbb85e6783682b7057
TP53-P72R,TP53,"This is a common variant was first reported as a polymorphism. It has since had mixed associations with cancer: Storey et al. conclude a 7x *increased* risk of HPV cancer for homozygotes vs hets, but Jones et al. find a 1.98x *decreased* risk for colorectal cancer. This variant may have significant impact on particular cancers, but it is unclear what effect it has on the overall burden of cancer.",Low,Uncertain,Pathogenic,0.63,Cancer,Unknown,Homozygous,1975675;9607760;15355915;19837266;20615891;22184967,rs1042522,0,chr17,7579472,C,http://evidence.pgp-hms.org/genomes?display_genome_id=964cc8fd3eb6ce92f25f4f0169ef0826cd995167&access_token=2a3c402922d936bbb85e6783682b7057
SP110-L425S,SP110,"This variant is associated with a slightly increased risk of tuberculosis. It is unclear whether it is itself causal, or in linkage disequilibrium with some other causal variant that has a stronger effect.",Low,Uncertain,Pathogenic,0.86,Immune system,Unknown,Homozygous,16803959,rs3948464,1,chr2,231050715,G,http://evidence.pgp-hms.org/genomes?display_genome_id=964cc8fd3eb6ce92f25f4f0169ef0826cd995167&access_token=2a3c402922d936bbb85e6783682b7057
HAMP-G71D,HAMP,"In a study from a small family (parent & two children), this variant was reported to have a modifier effect on hereditary haemochromatosis, increasing the severity of iron overload. Individuals were also homozygous or heterozygous for HFE C282Y. The variant was seen heterozygously in three of 1022 control chromosomes.",Low,Uncertain,Pathogenic,0.002,Blood,Recessive,Heterozygous,12915468,,1,chr19,35775902,A,http://evidence.pgp-hms.org/genomes?display_genome_id=964cc8fd3eb6ce92f25f4f0169ef0826cd995167&access_token=2a3c402922d936bbb85e6783682b7057
CYP2C9-R144C,CYP2C9,"This variant, also called CYP2C9*2, is a pharmacogenetic variant that modulates sensitivity for Warfarin (due to reduced metabolism). This variant is associated with Caucasians. The FDA has approved reduced recommended Warfarin dosage based on the presence of this variant.",Moderate,Well-established,Pharmacogenetic,0.097,Drug response;Metabolism,Unknown,Homozygous,8004131;15947090;17161452;17686967;19228618;19794411;19794412,rs1799853,3,chr10,96702047,T,http://evidence.pgp-hms.org/genomes?display_genome_id=964cc8fd3eb6ce92f25f4f0169ef0826cd995167&access_token=2a3c402922d936bbb85e6783682b7057
FUT2-W154X,FUT2,"This recessive protective variant confers resistance to norovirus (which causes stomach flu). 20% of Caucasians and Africans are homozygous for this variant and are ""non-secretors"": they do not express ABO blood type antigens in their saliva or mucosal surfaces. Most strains of norovirus bind to these antigens in the gut, and so this non-secretor status confers almost total resistantance to most types of norovirus. There are notable exceptions, some strains of norovirus bind a different target and are equally infectious for secretors and non-secretors.",Moderate,Well-established,Protective,0.49,Blood;Immune system,Recessive,Heterozygous,7876235;12692541;19625485;20031047;22025362,rs601338,5,chr19,49206674,A,http://evidence.pgp-hms.org/genomes?display_genome_id=964cc8fd3eb6ce92f25f4f0169ef0826cd995167&access_token=2a3c402922d936bbb85e6783682b7057
PRNP-M129V,PRNP,"This variant is associated with some protective effects for prion disease -- individuals homozygous for this variant are less susceptible to Creutzfeldt-Jakob, and Papua New Guinea individuals heterozygotes at this site are less susceptible to kuru.

",Low,Well-established,Protective,0.34,Other,Complex/Other,Homozygous,18236005;19081515,rs1799990,0,chr20,4680251,G,http://evidence.pgp-hms.org/genomes?display_genome_id=964cc8fd3eb6ce92f25f4f0169ef0826cd995167&access_token=2a3c402922d936bbb85e6783682b7057
NPC1-H215R,NPC1,"This variant is associated with a reduced risk of obesity, with an additive effect of -0.084 BMI per allele (an average of 0.54 pounds less, per allele, in a 5'6"" individual).





",Low,Likely,Protective,0.3,Metabolism,Complex/Other,Heterozygous,19151714;19174833;19910939,rs1805081,2,chr18,21140432,C,http://evidence.pgp-hms.org/genomes?display_genome_id=964cc8fd3eb6ce92f25f4f0169ef0826cd995167&access_token=2a3c402922d936bbb85e6783682b7057
TOR1A-D216H,TOR1A,This SNP has been shown to be benign and play a protective role against Dystonia.  ,Low,Likely,Protective,0.1,Nervous system,Unknown,Heterozygous,18519876;19380705;20669276,rs1801968,1,chr9,132580901,G,http://evidence.pgp-hms.org/genomes?display_genome_id=964cc8fd3eb6ce92f25f4f0169ef0826cd995167&access_token=2a3c402922d936bbb85e6783682b7057
IL7R-T244I,IL7R,"The reference genome variant for this allele has been associated with a slight increased risk of multiple sclerosis. Thus, this variant can be treated as a ""protective"" variant -- carriers of this variant are slightly less likely to have MS. Because the disease is rare and the effect of this variant is not very strong, the absolute decreased risk for carriers of this variant is less than .05% (less than 1 in 2000).",Low,Likely,Protective,0.21,Immune system;Nervous system,Unknown,Homozygous,12825072;17660530;17660816;17660817;21161391,rs6897932,0,chr5,35874575,T,http://evidence.pgp-hms.org/genomes?display_genome_id=964cc8fd3eb6ce92f25f4f0169ef0826cd995167&access_token=2a3c402922d936bbb85e6783682b7057
KCNJ11-K23E,KCNJ11,"This variant is associated with decreased risk of type 2 diabetes. It is unclear whether this variant has additive effects, or acts in a dominant or recessive manner. Assuming diabetes has a lifetime risk of 36%, we estimate a decreased risk of around 1-2% per copy of this variant.",Low,Likely,Protective,0.74,Metabolism,Unknown,Heterozygous,17463246;17463248;20054294,rs5219,2,chr11,17409572,C,http://evidence.pgp-hms.org/genomes?display_genome_id=964cc8fd3eb6ce92f25f4f0169ef0826cd995167&access_token=2a3c402922d936bbb85e6783682b7057
MTR-D919G,MTR,"This variant was weakly associated with a protective effect vs. colorectal cancer, but only in individuals with low alcohol consumption.


",Low,Uncertain,Protective,0.22,Cancer,Complex/Other,Heterozygous,10498402;14744749;17417062;17855192,rs1805087,1,chr1,237048500,G,http://evidence.pgp-hms.org/genomes?display_genome_id=964cc8fd3eb6ce92f25f4f0169ef0826cd995167&access_token=2a3c402922d936bbb85e6783682b7057
TYR-R402Q,TYR,"This is a frequent pigmentation polymorphism in Europeans that affects function of the Tyrosinase gene. It is associated with blue instead of green eyes and sun sensitivity. For the most part this variant is benign, but many individuals with ocular albinism (which affects only the eyes) carry this variant along with another more severe variant in the same gene.",Low,Well-established,Benign,0.2,Hearing and vision,Complex/Other,Heterozygous,1820207;7704033;11284711;18326704;18488027;18488028;19533789,rs1126809,0,chr11,89017961,A,http://evidence.pgp-hms.org/genomes?display_genome_id=964cc8fd3eb6ce92f25f4f0169ef0826cd995167&access_token=2a3c402922d936bbb85e6783682b7057
FANCI-P55L,FANCI,Probably benign.,Low,Likely,Benign,0.051,Other,Unknown,Heterozygous,17412408,rs62020347,,chr15,89803950,T,http://evidence.pgp-hms.org/genomes?display_genome_id=964cc8fd3eb6ce92f25f4f0169ef0826cd995167&access_token=2a3c402922d936bbb85e6783682b7057
COL6A3-D2831H,COL6A3,"Probably benign, reported by Pan et al. as a presumed-nonpathogenic variant in the gene.",Low,Likely,Benign,0.068,Other,Unknown,Heterozygous,9536084;15563506,rs36104025,,chr2,238247734,G,http://evidence.pgp-hms.org/genomes?display_genome_id=964cc8fd3eb6ce92f25f4f0169ef0826cd995167&access_token=2a3c402922d936bbb85e6783682b7057
TGM1-V518M,TGM1,"Probably a non-pathogenic polymorphism. It was initially thought to be involved in autosomal recessive congenital ichthyosis, but later authors found the variant in numerous healthy controls.",Low,Likely,Benign,0.011,Skin,Unknown,Heterozygous,19241467,rs35312232,,chr14,24724663,T,http://evidence.pgp-hms.org/genomes?display_genome_id=964cc8fd3eb6ce92f25f4f0169ef0826cd995167&access_token=2a3c402922d936bbb85e6783682b7057
NEFL-S472Shift,NEFL,"Although a frameshift in this gene would be predicted to cause Charcot-Marie Neuropathy, this particular position appears to reflect a single base insertion error/mutation in the reference genome (in other words, normal individuals are always homozygous for a deletion at this position relative to reference). See chr8:24,811,060-24,811,080 annotations on UCSC.",Low,Likely,Benign,,Nervous system,Unknown,Homozygous,,rs11340767,,,,,http://evidence.pgp-hms.org/genomes?display_genome_id=964cc8fd3eb6ce92f25f4f0169ef0826cd995167&access_token=2a3c402922d936bbb85e6783682b7057
FBN2-S2580L,FBN2,"Probably benign -- initially associated with congenital contractual arachnodactyly, but later reports classify it as a nonpathogenic polymorphism.",Low,Uncertain,Benign,0.078,Anatomical and congenital,Dominant,Heterozygous,9714438;10633129;16835936;17345643,rs2291628,,chr5,127609633,A,http://evidence.pgp-hms.org/genomes?display_genome_id=964cc8fd3eb6ce92f25f4f0169ef0826cd995167&access_token=2a3c402922d936bbb85e6783682b7057
GUCY2D-A52S,GUCY2D,"One publication suggested that this variant possibly causes Leber's congenital amaurosis in a recessive manner, but the frequency data (36% in 1000 genomes) contradicts any significant pathogenic effect.",Low,Uncertain,Benign,0.21,Hearing and vision,Recessive,Homozygous,8944027,rs61749665,,chr17,7906519,T,http://evidence.pgp-hms.org/genomes?display_genome_id=964cc8fd3eb6ce92f25f4f0169ef0826cd995167&access_token=2a3c402922d936bbb85e6783682b7057
MLH1-I219V,MLH1,"Computational evidence, functional assays, and case/control studies suggest this variant is probably benign.",Low,Uncertain,Benign,0.24,Other,Dominant,Heterozygous,11781295;12810663;17074586;17510385;17870204;19863800;20301390;22631669,rs1799977,0,chr3,37053568,G,http://evidence.pgp-hms.org/genomes?display_genome_id=964cc8fd3eb6ce92f25f4f0169ef0826cd995167&access_token=2a3c402922d936bbb85e6783682b7057
LOXL1-R141L,LOXL1,"Associated with exfoliative glaucoma & syndrome (XFG & XFS) in various populations, but with contradicting results (protective in Caucasians, pathogenic in Japanese). Based on this it seems the variation itself -- although it affects protein structure -- is not itself causing disease. Instead it is likely associated with other nearby causal variants. As such, it is evaluated as benign by GET-Evidence (which focuses on reporting causal variants). See detailed variant report for disease risk associations.",Low,Uncertain,Benign,0.26,Hearing and vision,Complex/Other,Homozygous,17690259;18450598;20142848,rs1048661,,chr15,74219546,T,http://evidence.pgp-hms.org/genomes?display_genome_id=964cc8fd3eb6ce92f25f4f0169ef0826cd995167&access_token=2a3c402922d936bbb85e6783682b7057
ERCC6-R1230P,ERCC6,Probably benign.,Low,Uncertain,Benign,0.07,Other,Unknown,Heterozygous,,rs4253211,,chr10,50678317,G,http://evidence.pgp-hms.org/genomes?display_genome_id=964cc8fd3eb6ce92f25f4f0169ef0826cd995167&access_token=2a3c402922d936bbb85e6783682b7057
WDR36-H212P,WDR36,Probably benign.,Low,Uncertain,Benign,0.00047,Other,Unknown,Heterozygous,18172102;19150991,,,chr5,110436345,C,http://evidence.pgp-hms.org/genomes?display_genome_id=964cc8fd3eb6ce92f25f4f0169ef0826cd995167&access_token=2a3c402922d936bbb85e6783682b7057
MAPT-Q230R,MAPT,Common polymorphism.,Low,Uncertain,Benign,0.042,Other,Unknown,Heterozygous,15365985,rs63750072,,chr17,44060859,G,http://evidence.pgp-hms.org/genomes?display_genome_id=964cc8fd3eb6ce92f25f4f0169ef0826cd995167&access_token=2a3c402922d936bbb85e6783682b7057
SLC45A2-L374F,SLC45A2,"Pigmentation allele for non-black hair, and consequently, possible increased susceptibility to malignant melanoma.",Low,Uncertain,Benign,0.69,Cancer,Unknown,Homozygous,15714523;17044855;18563784;18806926,rs16891982,,chr5,33951693,G,http://evidence.pgp-hms.org/genomes?display_genome_id=964cc8fd3eb6ce92f25f4f0169ef0826cd995167&access_token=2a3c402922d936bbb85e6783682b7057
PKP2-L366P,PKP2,This variant is a benign polymorphism.  ,Low,Uncertain,Benign,0.22,Other,Unknown,Heterozygous,19955750,rs1046116,,chr12,33021934,G,http://evidence.pgp-hms.org/genomes?display_genome_id=964cc8fd3eb6ce92f25f4f0169ef0826cd995167&access_token=2a3c402922d936bbb85e6783682b7057
PCSK9-G670E,PCSK9,This variant is likely benign. ,Low,Uncertain,Benign,0.89,Other,Unknown,Homozygous,19351729,rs505151,,chr1,55529187,A,http://evidence.pgp-hms.org/genomes?display_genome_id=964cc8fd3eb6ce92f25f4f0169ef0826cd995167&access_token=2a3c402922d936bbb85e6783682b7057
FANCA-S1088F,FANCA,"Probably benign. One report hypothesized this variant causing Fanconi Anemia, but the allele frequency (3-7%) is high enough to contradict a highly penetrant pathogenic effect. Later authors have concluded this is a polymorphism, not pathogenic.",Low,Uncertain,Benign,0.058,Blood,Unknown,Heterozygous,10094191;14695169,rs17233497,0,chr16,89815152,A,http://evidence.pgp-hms.org/genomes?display_genome_id=964cc8fd3eb6ce92f25f4f0169ef0826cd995167&access_token=2a3c402922d936bbb85e6783682b7057
CBLC-H405Y,CBLC,Probably benign.,Low,Uncertain,Benign,0.037,Other,Unknown,Heterozygous,19370762,rs3208856,,chr19,45296806,T,http://evidence.pgp-hms.org/genomes?display_genome_id=964cc8fd3eb6ce92f25f4f0169ef0826cd995167&access_token=2a3c402922d936bbb85e6783682b7057
RP1-N985Y,RP1,"Probably benign. One report linked this variant to high triglycerides, but a later paper found a nearby SNP with similar association and suggests that both findings are caused by linkage to an undiscovered causal variant.",Low,Uncertain,Benign,0.35,Metabolism,Unknown,Heterozygous,12764676;19364639,rs2293869,,chr8,55539395,T,http://evidence.pgp-hms.org/genomes?display_genome_id=964cc8fd3eb6ce92f25f4f0169ef0826cd995167&access_token=2a3c402922d936bbb85e6783682b7057
APOB-Y1422C,APOB,This position is almost certainly an error in the HG18 reference sequence. ,Low,Uncertain,Benign,1.0,Other,Unknown,Homozygous,,rs568413,,chr2,21235475,C,http://evidence.pgp-hms.org/genomes?display_genome_id=964cc8fd3eb6ce92f25f4f0169ef0826cd995167&access_token=2a3c402922d936bbb85e6783682b7057
TPCN2-G734E,TPCN2,Pigmentation allele.,Low,Uncertain,Benign,0.29,Other,Unknown,Homozygous,18488028,rs3829241,,chr11,68855363,A,http://evidence.pgp-hms.org/genomes?display_genome_id=964cc8fd3eb6ce92f25f4f0169ef0826cd995167&access_token=2a3c402922d936bbb85e6783682b7057
TAS2R38-A49P,TAS2R38,"This variant is strongly associated with causing the ""taster"" phenotype of phenylthiocarbamine (PTC) in a dominant manner.",Low,Uncertain,Benign,0.43,Other,Unknown,Heterozygous,12595690;15883422;20675712,rs713598,,chr7,141673345,G,http://evidence.pgp-hms.org/genomes?display_genome_id=964cc8fd3eb6ce92f25f4f0169ef0826cd995167&access_token=2a3c402922d936bbb85e6783682b7057
TAS2R38-I296V,TAS2R38,"This variant is associated with ""taster"" status of PTC, along with 49P and 262A. Due to linkage disequilibrium, the independent effects of positions 296 and 262 is unclear. The presence of 49P confers taster status in a dominant fashion, but in the absence of 49P, the presence of 262A/296V is still positively associated with tasting PTC.",Low,Uncertain,Benign,0.46,Other,Unknown,Homozygous,12595690;20675712,rs10246939,,chr7,141672604,C,http://evidence.pgp-hms.org/genomes?display_genome_id=964cc8fd3eb6ce92f25f4f0169ef0826cd995167&access_token=2a3c402922d936bbb85e6783682b7057
SPTA1-A970D,SPTA1,"This variant, also called alpha-IIa, has been seen frequently in individuals with recessive Hereditary spherocytosis. This appears to be the result of linkage to alpha-LEPRA (a C>T substitution at position -99 of intron 30); A970D is later reported as functionally neutral.",Low,Uncertain,Benign,0.037,Blood,Unknown,Heterozygous,8844207;9067503;15384986;16150946,rs35948326,,chr1,158624528,T,http://evidence.pgp-hms.org/genomes?display_genome_id=964cc8fd3eb6ce92f25f4f0169ef0826cd995167&access_token=2a3c402922d936bbb85e6783682b7057
TYR-S192Y,TYR,This variant is reported to affect skin pigmentation. It is associated with lighter skin in South Asians (OR 4-5) and with a lack of freckles in Europeans (OR 1.3).,Low,Uncertain,Benign,0.27,Skin,Unknown,Heterozygous,17952075;17999355,rs1042602,,chr11,88911696,A,http://evidence.pgp-hms.org/genomes?display_genome_id=964cc8fd3eb6ce92f25f4f0169ef0826cd995167&access_token=2a3c402922d936bbb85e6783682b7057
